Cargando…

Clinical importance of S100A9 in osteosarcoma development and as a diagnostic marker and therapeutic target

Objective: S100A9 is a calcium- and zinc-binding molecule of S100 family. The aim of the study was to evaluate the role of S100A9 in osteosarcoma (OS) and its value as a diagnostic and therapeutic target in OS. Methods: Quantitative real-time polymerase chain reaction (qRT-PCR), immunohistochemistry...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yongliang, Luo, Gongzeng, He, Dongyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527076/ https://www.ncbi.nlm.nih.gov/pubmed/31055998 http://dx.doi.org/10.1080/21655979.2019.1607709

Ejemplares similares

Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in osteosarcoma
por: Ma, Hangzhan, et al.
Publicado: (2018)

Increased SNAT1 is a marker of human osteosarcoma and potential therapeutic target
por: Wang, Miaomiao, et al.
Publicado: (2017)

Osteosarcoma mechanobiology and therapeutic targets
por: Shoaib, Zunaira, et al.
Publicado: (2021)

Characterization of the Tumor Microenvironment in Jaw Osteosarcomas, towards Prognostic Markers and New Therapeutic Targets
por: Bertin, Hélios, et al.
Publicado: (2023)

Urinary Nucleic Acid TSPAN13-to-S100A9 Ratio as a Diagnostic Marker in Prostate Cancer
por: Yan, Chunri, et al.
Publicado: (2015)

The Roles of KIFC1 in the Development of Osteosarcoma: Characterization of Potential Therapeutic Targets
por: Liang, Li-Yan, et al.
Publicado: (2022)

Neutrophil elastase as a diagnostic marker and therapeutic target in colorectal cancers
por: Ho, Ai-Sheng, et al.
Publicado: (2014)

S100 Proteins as Diagnostic and Prognostic Markers in Colorectal and Hepatocellular Carcinoma
por: Maletzki, Claudia, et al.
Publicado: (2012)

S100A8/A9 in Myocardial Infarction: A Promising Biomarker and Therapeutic Target
por: Cai, ZhuLan, et al.
Publicado: (2020)

mTOR: An attractive therapeutic target for osteosarcoma?
por: Ding, Liu, et al.
Publicado: (2016)

Pathogenic Roles of S100A8 and S100A9 Proteins in Acute Myeloid and Lymphoid Leukemia: Clinical and Therapeutic Impacts
por: Mondet, Julie, et al.
Publicado: (2021)

The Roles of Noncoding RNAs in the Development of Osteosarcoma Stem Cells and Potential Therapeutic Targets
por: Liu, Jinxin, et al.
Publicado: (2022)

miRNA-223 is a potential diagnostic and prognostic marker for osteosarcoma
por: Dong, Junbo, et al.
Publicado: (2016)

Maternal embryonic leucine zipper kinase serves as a poor prognosis marker and therapeutic target in osteosarcoma
por: Jeddo, Salim F.A., et al.
Publicado: (2020)

A special jubilee: 100 fake osteosarcoma articles
por: Bielack, S.S., et al.
Publicado: (2021)

MFNG is an independent prognostic marker for osteosarcoma
por: Gao, Yi, et al.
Publicado: (2023)

Therapeutic Implications of PPARγ in Human Osteosarcoma
por: Wagner, Eric R., et al.
Publicado: (2010)

S-Calprotectin (S100A8/S100A9): A Potential Marker of Inflammation in Patients with Psoriatic Arthritis
por: Hansson, Claes, et al.
Publicado: (2014)

S100A4 May Be a Good Prognostic Marker and a Therapeutic Target for Colon Cancer
por: Destek, Sabahattin, et al.
Publicado: (2018)

Systematic screening for potential therapeutic targets in osteosarcoma through a kinome-wide CRISPR-Cas9 library
por: Wu, Yuanzhong, et al.
Publicado: (2020)

Kinome-wide CRISPR-Cas9 knockout screens revealed PLK1 as a therapeutic target for osteosarcoma
por: Wang, Renxian, et al.
Publicado: (2023)

miR-9 depletion suppresses the proliferation of osteosarcoma cells by targeting p16
por: Gao, Song, et al.
Publicado: (2019)

Smoothened as a new therapeutic target for human osteosarcoma
por: Hirotsu, Masataka, et al.
Publicado: (2010)

sCLU as prognostic biomarker and therapeutic target in osteosarcoma
por: Ma, Jinfeng, et al.
Publicado: (2019)

ADCK1 is a potential therapeutic target of osteosarcoma
por: Zhuo, Bao-biao, et al.
Publicado: (2022)

S100A8 and S100A9 in Hematologic Malignancies: From Development to Therapy
por: Razmkhah, Farnaz, et al.
Publicado: (2023)

S100A8/A9 is the first predictive marker for neonatal sepsis
por: Pirr, Sabine, et al.
Publicado: (2021)

Surface osteosarcoma: Clinical features and therapeutic implications
por: Nouri, H., et al.
Publicado: (2015)

Screening of potential diagnostic markers and therapeutic targets against colorectal cancer
por: Tian, XiaoQing, et al.
Publicado: (2015)

MicroRNAs as diagnostic markers and therapeutic targets for traumatic brain injury
por: Martinez, Bridget, et al.
Publicado: (2017)

Arterial Hypertension and Interleukins: Potential Therapeutic Target or Future Diagnostic Marker?
por: Tanase, Daniela Maria, et al.
Publicado: (2019)

The implications of exosomes in pregnancy: emerging as new diagnostic markers and therapeutics targets
por: Ghafourian, Mehri, et al.
Publicado: (2022)

S100A4 Is a Strong Negative Prognostic Marker and Potential Therapeutic Target in Adenocarcinoma of the Stomach and Esophagus
por: Treese, Christoph, et al.
Publicado: (2022)

Emerging targets for cancer treatment: S100A9/RAGE
por: Valiente, M., et al.
Publicado: (2023)

RNA sequencing for ligature induced periodontitis in mice revealed important role of S100A8 and S100A9 for periodontal destruction
por: Maekawa, Shogo, et al.
Publicado: (2019)

Serum miR-95-3p is a diagnostic and prognostic marker for osteosarcoma
por: Niu, Junjie, et al.
Publicado: (2016)

Identification of Abnormal Spindle Microtubule Assembly as a Promising Therapeutic Target for Osteosarcoma
por: Lin, Peng, et al.
Publicado: (2020)

Is CDK9 a promising target for both primary and metastatic osteosarcoma?
por: Qin, Jiang-Jiang
Publicado: (2019)

Myc is a prognostic biomarker and potential therapeutic target in osteosarcoma
por: Feng, Wenlong, et al.
Publicado: (2020)

Identification of RALA as a Therapeutic Target and Prognostic Predictor of Osteosarcoma
por: Fan, Gentao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lujem0ii0arj17btluoms4k6gt